These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6270843)

  • 21. [Biochemical mechanism of blood platelet release reaction, aggregation and adhesiveness].
    Hidaka H; Ikukawa S
    Nihon Rinsho; 1978 Dec; 36(12):3798-804. PubMed ID: 219272
    [No Abstract]   [Full Text] [Related]  

  • 22. Investigation of the effects of phospholipase C on human platelets: evidence that aggregation induced by phospholipase C is independent of prostaglandin generation, released ADP and is modulated by cyclic AMP.
    Akbar H; Navran SS; Chang J; Miller DD; Feller DR
    Thromb Res; 1982 Aug; 27(4):405-17. PubMed ID: 6293114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosine dephosphorylation, but not phosphorylation, of p130Cas is dependent on integrin alpha IIb beta 3-mediated aggregation in platelets: implication of p130Cas involvement in pathways unrelated to cytoskeletal reorganization.
    Ohmori T; Yatomi Y; Inoue K; Satoh K; Ozaki Y
    Biochemistry; 2000 May; 39(19):5797-807. PubMed ID: 10801330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interrelationship between calcium and cyclic nucleotides in platelet function.
    Kume S; Kariya T
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1103-12. PubMed ID: 6277132
    [No Abstract]   [Full Text] [Related]  

  • 25. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
    Macfarlane DE; Srivastava PC; Mills DC
    J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphine-potentiated platelet aggregation in in vitro and platelet plug formation in in vivo experiments.
    Hsiao G; Shen MY; Fang CL; Chou DS; Lin CH; Chen TF; Sheu JR
    J Biomed Sci; 2003; 10(3):292-301. PubMed ID: 12711856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro effect of a thymic epithelial culture supernate or thymosin fraction 5 on rabbit platelet aggregation and intracellular cyclic AMP levels.
    Hashimoto S; Itoh Y; Kawaguchi A; Mizuno Y; Muraoka M; Tsuchiya M
    J Cell Physiol; 1987 Dec; 133(3):499-506. PubMed ID: 2826498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma lipids and platelet membrane fluidity in essential hypertension.
    Le Quan Sang KH; Mazeaud M; Astarie C; Duranthon V; Driss F; Devynck MA
    Thromb Haemost; 1993 Jan; 69(1):70-6. PubMed ID: 8383361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular pH affects platelet aggregation associated with modulation of store-operated Ca(2+) entry.
    Marumo M; Suehiro A; Kakishita E; Groschner K; Wakabayashi I
    Thromb Res; 2001 Dec; 104(5):353-60. PubMed ID: 11738078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of antithrombotic drugs and its clinical use--related to platelet function].
    Matsuno K
    Nihon Rinsho; 1989 Apr; 47(4):921-8. PubMed ID: 2545946
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition by forskolin of cytosolic calcium rise, shape change and aggregation in quin2-loaded human platelets.
    Sage SO; Rink TJ
    FEBS Lett; 1985 Aug; 188(1):135-40. PubMed ID: 2410292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired cAMP metabolism associated with abnormal function of thrombopathic canine platelets.
    Boudreaux MK; Dodds WJ; Slauson DO; Catalfamo JL
    Biochem Biophys Res Commun; 1986 Oct; 140(2):595-601. PubMed ID: 2430569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP.
    Alheid U; Reichwehr I; Förstermann U
    Eur J Pharmacol; 1989 May; 164(1):103-10. PubMed ID: 2546782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane depolarization inhibits thrombin-induced calcium influx and aggregation in human platelets.
    Kovács T; Tordai A; Szász I; Sarkadi B; Gárdos G
    FEBS Lett; 1990 Jun; 266(1-2):171-4. PubMed ID: 1694785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is prostacyclin a physiologically important circulating anti-platelet agent?
    Steer ML; MacIntyre DE; Levine L; Salzman EW
    Nature; 1980 Jan; 283(5743):194-5. PubMed ID: 6243178
    [No Abstract]   [Full Text] [Related]  

  • 36. [Platelet physiology. Advances in platelet reactivity. Review].
    Vizcaíno-Salazar G
    Invest Clin; 1994 Mar; 35(1):41-62. PubMed ID: 8054381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
    Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
    Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function.
    Aszódi A; Pfeifer A; Ahmad M; Glauner M; Zhou XH; Ny L; Andersson KE; Kehrel B; Offermanns S; Fässler R
    EMBO J; 1999 Jan; 18(1):37-48. PubMed ID: 9878048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editorial comments: cyclic nucleotides and the pathophysiology of the cardiovascular system.
    Sands H
    Adv Cyclic Nucleotide Res; 1980; 12():93-5. PubMed ID: 6250377
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adrenergic receptors of thrombocytes].
    Alekseeva EA; Golikov PP
    Gematol Transfuziol; 1989 Feb; 34(2):49-54. PubMed ID: 2540057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.